A Prospective Randomized Study to Compare Clinical Outcome of External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) With or Without Concurrent Cisplatin on the Day of ICBT Insertion in Treatment of Locally Advanced Carcinoma CervixD
Received Date: Sep 08, 2021 / Accepted Date: Sep 22, 2021 / Published Date: Sep 29, 2021
Abstract
The study reviews that cervical cancer is among the most commonly diagnosed cancers in women worldwide. In 2018, according to the GLOBOCAN estimates there were 569,847 new cases of cervical cancer worldwide (4th most common cancer in women worldwide, accounting for 6.9% of all cancers in women apart from non-melanoma skin cancers). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. In contrast to developed countries, cervical cancer is a public health problem in developing countries.
Keywords: Cervical cancer; GLOBOCAN; Lung cancer; Melanoma; Brachytherapy
Citation: Alim S (2021) A Prospective Randomized Study to Compare Clinical Outcome of External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) With or Without Concurrent Cisplatin on the Day of ICBT Insertion in Treatment of Locally Advanced Carcinoma Cervix. J Oncol Res Treat 6:166. Doi: 10.4172/aot.1000166
Copyright: © 2021 Alim S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 1763
- [From(publication date): 0-2021 - Nov 18, 2024]
- Breakdown by view type
- HTML page views: 1351
- PDF downloads: 412
